kynurenine has been researched along with Cardiac Failure in 10 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Protocatechuic acid (3,4-dihydroxybenzoic acid) prevents oxidative stress, inflammation and cardiac hypertrophy." | 8.31 | Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. ( Bai, L; Han, X; He, X; Jeon, MJ; Jeong, MH; Jeong, SM; Kee, HJ; Kee, SJ; Kim, SH; Zhou, H, 2023) |
"Metabolites of the kynurenine pathway (mKP) relate to important aspects of heart failure pathophysiology, such as inflammation, energy-homeostasis, apoptosis, and oxidative stress." | 7.96 | Plasma kynurenines and prognosis in patients with heart failure. ( Giil, LM; Lund, A; Midttun, Ø; Nordrehaug, JE; Nygård, O; Pedersen, EK; Slettom, G; Solvang, SH; Ueland, PM; Ulvik, A, 2020) |
"It was our objective to increase the body of data regarding the value of kynurenine as a biomarker in chronic heart failure (CHF)." | 7.91 | Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease. ( Armbruster, FP; Bankovic, D; Boschann, F; Dschietzig, TB; Kellner, KH; Klüsener, R; Meinitzer, A; Melzer, C; Mitrovic, V; Ruppert, J; Sasse, K, 2019) |
"Kynurenine is a circulating metabolite from the essential amino acid tryptophan." | 6.82 | Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). ( Anker, SD; Doehner, W; Dschietzig, TB; Ebner, N; Konishi, M; Schefold, JC; Springer, J; von Haehling, S, 2016) |
"Protocatechuic acid (3,4-dihydroxybenzoic acid) prevents oxidative stress, inflammation and cardiac hypertrophy." | 4.31 | Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. ( Bai, L; Han, X; He, X; Jeon, MJ; Jeong, MH; Jeong, SM; Kee, HJ; Kee, SJ; Kim, SH; Zhou, H, 2023) |
"Metabolites of the kynurenine pathway (mKP) relate to important aspects of heart failure pathophysiology, such as inflammation, energy-homeostasis, apoptosis, and oxidative stress." | 3.96 | Plasma kynurenines and prognosis in patients with heart failure. ( Giil, LM; Lund, A; Midttun, Ø; Nordrehaug, JE; Nygård, O; Pedersen, EK; Slettom, G; Solvang, SH; Ueland, PM; Ulvik, A, 2020) |
"It was our objective to increase the body of data regarding the value of kynurenine as a biomarker in chronic heart failure (CHF)." | 3.91 | Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease. ( Armbruster, FP; Bankovic, D; Boschann, F; Dschietzig, TB; Kellner, KH; Klüsener, R; Meinitzer, A; Melzer, C; Mitrovic, V; Ruppert, J; Sasse, K, 2019) |
"Kynurenine is a circulating metabolite from the essential amino acid tryptophan." | 2.82 | Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). ( Anker, SD; Doehner, W; Dschietzig, TB; Ebner, N; Konishi, M; Schefold, JC; Springer, J; von Haehling, S, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 5 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bekfani, T | 1 |
Bekhite, M | 1 |
Neugebauer, S | 1 |
Derlien, S | 1 |
Hamadanchi, A | 1 |
Nisser, J | 1 |
Hilse, MS | 1 |
Haase, D | 1 |
Kretzschmar, T | 1 |
Wu, MF | 1 |
Lichtenauer, M | 1 |
Kiehntopf, M | 1 |
von Haehling, S | 2 |
Schlattmann, P | 1 |
Lehmann, G | 1 |
Franz, M | 1 |
Möbius-Winkler, S | 1 |
Schulze, C | 1 |
Bai, L | 1 |
Han, X | 1 |
Kee, HJ | 1 |
He, X | 1 |
Kim, SH | 1 |
Jeon, MJ | 1 |
Zhou, H | 1 |
Jeong, SM | 1 |
Kee, SJ | 1 |
Jeong, MH | 1 |
Lund, A | 1 |
Nordrehaug, JE | 1 |
Slettom, G | 1 |
Solvang, SH | 1 |
Pedersen, EK | 1 |
Midttun, Ø | 1 |
Ulvik, A | 1 |
Ueland, PM | 1 |
Nygård, O | 1 |
Giil, LM | 1 |
Sousa, A | 1 |
Ribeiro, C | 1 |
Gonçalves, VMF | 1 |
Barbosa, J | 1 |
Peixoto, B | 1 |
Andrade, A | 1 |
Silva, P | 1 |
Andrade, JP | 1 |
Leal, S | 1 |
Razquin, C | 1 |
Ruiz-Canela, M | 1 |
Toledo, E | 1 |
Hernández-Alonso, P | 1 |
Clish, CB | 1 |
Guasch-Ferré, M | 1 |
Li, J | 1 |
Wittenbecher, C | 1 |
Dennis, C | 1 |
Alonso-Gómez, A | 1 |
Fitó, M | 1 |
Liang, L | 1 |
Corella, D | 1 |
Gómez-Gracia, E | 1 |
Estruch, R | 1 |
Fiol, M | 1 |
Lapetra, J | 1 |
Serra-Majem, L | 1 |
Ros, E | 1 |
Aros, F | 1 |
Salas-Salvadó, J | 1 |
Hu, FB | 1 |
Martínez-González, MA | 1 |
Su, J | 1 |
Wang, J | 1 |
Ma, Y | 1 |
Li, Q | 1 |
Yang, Y | 1 |
Huang, L | 1 |
Wang, H | 1 |
Li, H | 1 |
Wang, Z | 1 |
Tong, J | 1 |
Huang, D | 1 |
Bai, X | 1 |
Yu, M | 1 |
Bu, L | 1 |
Fei, J | 1 |
Huang, F | 1 |
Dschietzig, TB | 2 |
Kellner, KH | 1 |
Sasse, K | 1 |
Boschann, F | 1 |
Klüsener, R | 1 |
Ruppert, J | 1 |
Armbruster, FP | 1 |
Bankovic, D | 1 |
Meinitzer, A | 1 |
Mitrovic, V | 1 |
Melzer, C | 1 |
Zhang, Y | 1 |
Blasco-Colmenares, E | 1 |
Harms, AC | 1 |
London, B | 1 |
Halder, I | 1 |
Singh, M | 1 |
Dudley, SC | 1 |
Gutmann, R | 1 |
Guallar, E | 1 |
Hankemeier, T | 1 |
Tomaselli, GF | 1 |
Cheng, A | 1 |
Konishi, M | 1 |
Ebner, N | 1 |
Springer, J | 1 |
Schefold, JC | 1 |
Doehner, W | 1 |
Anker, SD | 1 |
Schroecksnadel, K | 1 |
Wirleitner, B | 1 |
Fuchs, D | 1 |
2 trials available for kynurenine and Cardiac Failure
Article | Year |
---|---|
Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Diet, Mediterranean; Female; Hea | 2021 |
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
Topics: Age Factors; Aged; Body Mass Index; Disease-Free Survival; Female; Heart Failure; Humans; Kidney; Ky | 2016 |
8 other studies available for kynurenine and Cardiac Failure
Article | Year |
---|---|
Metabolomic Profiling in Patients with Heart Failure and Exercise Intolerance: Kynurenine as a Potential Biomarker.
Topics: Biomarkers; Heart Failure; Humans; Kynurenine; Metabolomics; Stroke Volume | 2022 |
Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase.
Topics: Animals; Cardiomegaly; Heart Failure; Isoproterenol; Kynurenine; Kynurenine 3-Monooxygenase; Mice; M | 2023 |
Plasma kynurenines and prognosis in patients with heart failure.
Topics: Aged; Biomarkers; Case-Control Studies; Coronary Artery Disease; Female; Heart Failure; Humans; Kynu | 2020 |
Development and validation of a liquid chromatography method using UV/fluorescence detection for the quantitative determination of metabolites of the kynurenine pathway in human urine: Application to patients with heart failure.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Heart Failure; Humans; Kynurenine; Mal | 2021 |
Inflammation associated with chronic heart failure leads to enhanced susceptibility to depression.
Topics: Animals; Brain; Chronic Disease; Cytokines; Depression; Heart Failure; Hypothalamo-Hypophyseal Syste | 2019 |
Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Female; Heart Failure; Humans; Immunoassay; Ky | 2019 |
Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients.
Topics: Aged; Amines; Arginine; Biomarkers; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Co | 2016 |
Anemia and congestive heart failure.
Topics: Anemia; Causality; Cell Division; Chronic Disease; Comorbidity; Dioxygenases; Heart Failure; Hematop | 2003 |